Volume 113, Nº 6, December 2019
DOI: http://www.dx.doi.org/10.5935/abc.20190125
ORIGINAL ARTICLE
Nrf2, NF-κB and PPARβ/δ mRNA Expression Profile in Patients with Coronary Artery Disease
Jaqueline Ermida Barbosa
Milena Barcza Stockler-Pinto
Beatriz Oliveira da Cruz
Ana Carla Tavares da Silva
Juliana Saraiva Anjos
Claudio Tinoco Mesquita
Denise Mafra
Ludmila F. M. F. Cardozo
Dr. Ludmila F. M. F. Cardozo
Abstract
Background: Oxidative stress and inflammation are present in coronary artery disease (CAD) and are linked to the activation of the transcription nuclear factor kappa B (NF-κB). To attenuate these complications, transcription factors like nuclear factor erythroid 2-related factor 2 (Nrf2) and peroxisome proliferator-activated receptor-β/δ (PPARβ/δ) can be activated to inhibit NF-κB. However, the available data on expression of NF-κB, Nrf2 and PPARβ/δ in CAD patients are limited.
Objective: To evaluate the expression of the transcription factors NF-κB and Nrf2 and PPAR𝛽/𝛿 in CAD patients.
Methods: Thirty-five patients (17 men, mean age 62.4 ± 7.55 years) with CAD and twelve patients (5 men, mean age 63.50 ± 11.46 years) without CAD were enrolled. Peripheral blood mononuclear cells (PBMCs) were isolated and processed for mRNA expression of Nrf2, NF-κB, NADPH: quinone oxidoreductase 1 (NQO1) and PPARβ/δ mRNAs using quantitative real-time polymerase chain reaction (qPCR). p < 0.05 was considered statistically significant.
Results: There was no difference in the mRNA expressions of Nrf2 (1.35 ± 0.57), NF-κB (1.08 ± 0.50) or in the antioxidante enzyme NQO1 (1.05 ± 0.88) in the CAD group compared to the group without CAD (1.16 ± 0.76, 0.95 ± 0.33, 0.81 ± 0.55, respectively). However, PPARβ/δ was highest expressed in the CAD group (1.17 ± 0.86 vs. 0.56 ± 0.34, p = 0.008).
Conclusion: The main finding of this study was the PPARβ/δ being more expressed in the PBMC of patients with CAD compared to the control group, whereas no differences were observed in Nrf2 or NF-κB mRNA expressions. (Arq Bras Cardiol. 2019; 113(6):1121-1127)
Keywords: Coronary Artery Disease; Oxidative Stress; Inflammation; Obesity; Hypertension; Dyslipidemias; Risk Factors/prevalence; Myocardial Infarction; Heart Failure.